Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romeo Hizon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|March 12, 2005
Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCRDobryan M Tracz, David A Boyd, Louis Bryden, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in CanadaDavid A Boyd, Tim Du, Romeo Hizon, et al.
FEMS Microbiology Letters|March 1, 2007
ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolatesDobryan M Tracz, David A Boyd, Romeo Hizon, et al.
Canadian Journal of Microbiology|February 25, 2025
Surveillance of <i>Clostridioides difficile</i> in Canadian retail meat and genomic linkages to community-associated human clinical infections in CanadaPaula E Pidsadny, Tim Du, Romeo Hizon, et al.
Plos One|January 26, 2013
Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolateTarah Lynch, Patrick Chong, Jason Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2011
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbationsMichael R Mulvey, Malcolm Doupe, Michael Prout, et al.
Journal of the Pediatric Infectious Diseases Society|January 31, 2023
Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020Anada Silva, Tim Du, Kelly B Choi, et al.
Infection Control and Hospital Epidemiology|August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemicKelly B Choi, Tim Du, Anada Silva, et al.
Emerging Infectious Diseases|April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019Tim Du, Kelly B Choi, Anada Silva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|March 12, 2005
Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCRDobryan M Tracz, David A Boyd, Louis Bryden, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in CanadaDavid A Boyd, Tim Du, Romeo Hizon, et al.
FEMS Microbiology Letters|March 1, 2007
ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolatesDobryan M Tracz, David A Boyd, Romeo Hizon, et al.
Canadian Journal of Microbiology|February 25, 2025
Surveillance of <i>Clostridioides difficile</i> in Canadian retail meat and genomic linkages to community-associated human clinical infections in CanadaPaula E Pidsadny, Tim Du, Romeo Hizon, et al.
Plos One|January 26, 2013
Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolateTarah Lynch, Patrick Chong, Jason Zhang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2011
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbationsMichael R Mulvey, Malcolm Doupe, Michael Prout, et al.
Journal of the Pediatric Infectious Diseases Society|January 31, 2023
Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020Anada Silva, Tim Du, Kelly B Choi, et al.
Infection Control and Hospital Epidemiology|August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemicKelly B Choi, Tim Du, Anada Silva, et al.
Emerging Infectious Diseases|April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019Tim Du, Kelly B Choi, Anada Silva, et al.
Pageof 1